Outlook Therapeutics, Inc. ( OTLK) - Stock Earnings
OTLK Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -23.1 million USD | -1.2 million USD |
| 2026Q1 | -4.5 million USD | 127439 USD |
| 2026Q2 | -20.3 million USD | 9000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
OTLK Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -59.0 million USD | — USD |
| 2024 | -75.4 million USD | 170124 USD |
| 2025 | -62.4 million USD | 1.4 million USD |
| 2026 Est. | — | — |
OTLK
Price: $0.49
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.69 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 308347
Market Capitalization: 107.0 million